Stants Kristen

Chief People Officer at DNTH

Sold, on record
$39k
Dollars the filings state
Form 4 sales
1
Latest Sep 16, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • DNTHDianthus Therapeutics, Inc. /DE/Chief People Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. Sep 16, 2021Unusual

    DNTH

    Sold 28.7% of their holdings

    $39k5,736 shares at $6.73

    Filed Sep 20, 2021Form 4

1 of 1

Every transaction

Every transaction on a Form 4 or Form 5 by Stants Kristen
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Nov 30, 2022Dec 2, 2022DNTHChief People OfficerAwarded3,000$0.94$3k20,264SEC
Aug 1, 2022Aug 1, 2022DNTHChief People OfficerAwardedStock Option (Right to Buy)85,00085,000SEC
May 31, 2022Jun 6, 2022DNTHChief People OfficerAwarded3,000$0.99$3k17,264SEC
May 17, 2022May 19, 2022DNTHChief People OfficerAwardedStock Option (Right to Buy)50,00050,000SEC
Feb 15, 2022Feb 17, 2022DNTHChief People OfficerAwardedStock Option (Right to Buy)85,00085,000SEC
Sep 16, 2021Sep 20, 2021DNTHChief People OfficerSold5,736$6.73$39k14,264SEC
Sep 14, 2021Sep 16, 2021DNTHChief People OfficerAwarded20,00020,000SEC
Aug 2, 2021Aug 3, 2021DNTHChief People OfficerAwardedStock Option (Right to Buy)67,50067,500SEC
Feb 11, 2021Feb 16, 2021DNTHChief People OfficerAwardedStock Option (Right to Buy)67,50067,500SEC

Sales and notices (1)

Form 144 notices and Form 4 sales by Stants Kristen
Source
Sep 16, 2021Sep 20, 2021DNTHChief People OfficerForm 4 sale5,736$39k28.7%UnusualSEC